SCHEMBL24609667

SCHEMBL24609667

c1ccc(-c2ccc3c(ccc4c5cc(-c6cc(-c7ccccn7)nc(-c7ccccn7)c6)ccc5nc(-c5ccccc5)c34)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.39
▸ METAP1 P53582 5/20 0.39
▸ CCR1 P32246 2/20 0.38
▸ CCR5 P51681 2/20 0.38
▸ CCR8 P51685 2/20 0.38
▸ MAPK1 P28482 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KDM4E B2RXH2 4/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ HTT P42858 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ RXFP1 Q9HBX9 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ ALPL P05186 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ ALPI P09923 1/20 0.36
▸ ALPG P10696 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24609721 0.94 DHODH (0.39) DHODHMETAP1CCR1CCR5CCR8
SCHEMBL24609998 0.92 CYP2C9 (0.38) DHODHMETAP1CCR1CCR5CCR8
SCHEMBL24609831 0.92 DHODH (0.44) DHODHMETAP1CCR1CCR5CCR8
SCHEMBL24609659 0.90 CCR1 (0.35) DHODHMETAP1CCR1CCR5CCR8
SCHEMBL24609712 0.87 CYP2C9 (0.37) DHODHMETAP1CCR1CCR5CCR8
SCHEMBL24609623 0.84 CYP2C9 (0.42) DHODHMETAP1TSHRHSD17B10KDM4E
SCHEMBL24609914 0.83 CCR1 (0.35) DHODHMETAP1CCR1CCR5CCR8
SCHEMBL24609638 0.80 MEN1 (0.42) DHODHKDM4ENPC1LMNASMN1; SMN2
SCHEMBL17915160 0.80 METAP1 (0.42) DHODHMETAP1CCR1CCR5CCR8
SCHEMBL24609637 0.79 MEN1 (0.44) DHODHHSD17B10KDM4ELMNARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213098-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213098-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 DHODH 247/4885METAP1 2919/4885CCR1 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback